SavedAdd your journal

Journals / Arşiv Kaynak Tarama Dergisi / 2011 / Cilt: 20 - Sayı: 2

Obstructive Sleep Apnea Syndrome: Pathophysıology, Diagnosis and Treatment

Obstrüktif Uyku Apne Sendromu: Patofizyoloji, Tanı ve Tedavi

Emrah KARA
Pages
118–129
Publication Date
2011-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, the pathophysiology, surgical and non surgical treatment modalities for OSAS were discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obstructive sleep apnea syndrome (OSAS), is a dangerous disease that effect millions of people around the world.
📊
Key Findings & Data:OSAS can be treated effectively with continious positive airway pressure (CPAP) while others do not tolerate this treatment modality for various reasons.
💡
Conclusion & Impact:In this article, the pathophysiology, surgical and non surgical treatment modalities for OSAS were discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:uyku apnesi · cerrahi · tedavi

Abstract

Obstructive sleep apnea syndrome (OSAS), is a dangerous disease that effect millions of people around the world. OSAS leads to serious comorbidities as well as it reduces the quality of life for patients. Many people do not recognize the disease or live undiagnosed for several years. OSAS can be treated effectively with continious positive airway pressure (CPAP) while others do not tolerate this treatment modality for various reasons. In this article, the pathophysiology, surgical and non surgical treatment modalities for OSAS were discussed.

Özet

Obstrüktif uyku apne sendromu (OUAS), dünya çapında milyonlarca insanı etkileyen, ciddi komorbiditelere yol açan, hastaların yaşam kalitelerini düşüren tehlikeli bir hastalıktır. Birçok hasta uzun yıllar teşhiş edilmeden veya hastalığı fark etmeden yaşamaktadır. Hastalık, sürekli pozitif hava yolu basıncı uygulaması (CPAP) ile etkin biçimde tedavi edilebilirken, bir kısım hasta çeşitli sebeplerden dolayı bu tedaviyi reddetmektedir. Bu makale, OUAS fizyopatolojisi, cerrahi ve cerrahi olmayan tedavi yöntemleri üzerine değinecektir.

🔖

Cite This Article

KARA, E. (2011). Obstructive Sleep Apnea Syndrome: Pathophysıology, Diagnosis and Treatment. Arşiv Kaynak Tarama Dergisi, Cilt: 20 - Sayı: 2, 118–129. https://ajindex.com/articles/466238

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Meyer JB, Knudson RC. The sleep apnea syndrome. Part I: diagnosis. J Prosthet Dent 1989; 62: 675-679.
  2. Shahar E, Whitney CW, Redline S et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001 Jan;163(1):19-25. 3. Reichmuth KJ, Austin D, Skatrud JB et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med. 2005 Dec 15;172(12):1590-5. Epub 2005 Sep 28. Lombardi C, Rocchi R, Montagna P et al.Obstructive sleep apnea syndrome: a cause of acute delirium. J Clin Sleep Med. 2009 Dec 15;5(6):569-70.
  3. Luboshitzky R, Aviv A, Hefetz A et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab. 2002 Jul;87(7):3394-8. 6. Kajaste S, Brander PE, Telakivi T et al. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med. 2004 Mar;5(2):125-31 7. Smith IE, Quinnell TG. Pharmacotherapies for obstructive sleep apnoea: where are we now? Drugs. 2004;64(13):1385-99.
  4. Block AJ, Wynne JW, Boysen PG et al. Menopause, medroxyprogesterone and breathing during sleep. Am J Med 1981; 70: 506-10.
  5. Whyte K, Gould G, AMie A et al. Role of protriptyline and acetazolamide in the sleep apnoea/hypopnea syndrome. Sleep 1988; 11:463-72.
  6. Smith PL, Haponik EF, Allen RP et al. The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis 1983;127:8-13.
  7. Sunderram J, Parisi RA, Strobel RJ. Serotonergic stimulation of the genioglossus and the response to nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162:925-9.
  8. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991; 100:416-21.
  9. Kraiczi H, Hedner J, Dahlof P et al. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 1999; 22: 61-7.
  10. Ip MS, Tse HF, Lam B et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004 Feb 1;169(3):348-53
  11. Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis. 2009 Mar-Apr;51(5):434-51.
  12. Harsch IA, Schahin SP, Brückner K et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep ap